RITUXIMAB IN PEDIATRIC RHEUMATOLOGY
The article presents literature review on the role of B-lymphocytes in pathogenesis of rheumatologic diseases and on the administration of chimeric anti-CD20 monoclonal antibodies — rituximab — for treatment of systemic lupus erythematosus, systemic vasculitis, juvenile dermatomyositis, and juvenile...
Main Authors: | E.I. Alexeeva, R.V. Denisova, S.I. Valieva, T.M. Bzarova, A.O. Lisitsyn |
---|---|
Format: | Article |
Language: | English |
Published: |
"Paediatrician" Publishers LLC
2010-05-01
|
Series: | Voprosy Sovremennoj Pediatrii |
Online Access: | https://vsp.spr-journal.ru/jour/article/view/891 |
Similar Items
-
RITUXIMAB IN PEDIATRIC RHEUMATOLOGY
by: E.I. Alexeeva, et al.
Published: (2010-01-01) -
EXPERIENCE OF TREATMENT WITH IBANDRONIC ACID IN PATIENTS WITH SEVERE RHEUMATOLOGICAL DISEASES AND SYSTEMIC OSTEOPOROSIS
by: A.O. Lisitsyn, et al.
Published: (2010-01-01) -
EXPERIENCE OF TREATMENT WITH IBANDRONIC ACID IN PATIENTS WITH SEVERE RHEUMATOLOGICAL DISEASES AND SYSTEMIC OSTEOPOROSIS
by: A.O. Lisitsyn, et al.
Published: (2010-01-01) -
NEW OPPORTUNITIES OF TREATMENT OF DIFFERENT TYPES OF JUVENILE ARTHRITIS WITH MONOCLONAL ANTIBODIES TO THE INTERLEUKIN 6 RECEPTOR
by: E.I. Alexeeva, et al.
Published: (2010-01-01) -
NEW OPPORTUNITIES OF TREATMENT OF DIFFERENT TYPES OF JUVENILE ARTHRITIS WITH MONOCLONAL ANTIBODIES TO THE INTERLEUKIN 6 RECEPTOR
by: E.I. Alexeeva, et al.
Published: (2010-01-01)